BEYFORTUS
We will be changing our web hosting provider during the next few days.
During this time, the site may work slowly or be unavailable.
We apologize for the inconvenience and kindly ask you to be patient!
Google image searchProduct monograph
Active ingredient
nirsevimab, 50 MG/0.5 ML
DIN: 02537206
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR
Description: SINGLE-USE PRE-FILLED SYRINGE
Schedule: Schedule D
Company: SANOFI PASTEUR LIMITED
Date: 21-OCT-2024
ATC:
- J06 — IMMUNE SERA AND IMMUNOGLOBULINS (ATC, ATC/DDD, )
- J06B — IMMUNOGLOBULINS (ATC, ATC/DDD)
- J06BD — Antiviral monoclonal antibodies (ATC, ATC/DDD)
- J06BD08 — NIRSEVIMAB (ATC/DDD)
